LORETTA VAN REUTER: Open Payments
NPI 1942725007 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$341 in 17 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $424 · 2025 $341
Food & beverage: $341
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $67 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Alnylam Pharmaceuticals Inc. | 2 | $49 |
| ABBVIE INC. | 2 | $45 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| PFIZER INC. | 2 | $31 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $18 |
| BridgeBio Pharma, Inc. | 1 | $16 |
Products named: JARDIANCE, FARXIGA, ONPATTRO, LEQVIO, ELIQUIS, UBRELVY, TEFLARO, VERQUVO.
Industry payments across PA — which companies pay providers there.
